Organization | Hypera Pharma

Hypera Pharma Report issue

For profit Phase 3 Phase 4

Founded: Sao Paulo Brazil (2008)

Status: No NME R&D (2008)

Organization Overview

First Clinical Trial

None

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

None

Timeline

NOW

Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (3)

Key: Hypera Pharma (0) Acquired (3)

acetaminophen (tylenol) (1 trial)

ibuprofen (motrin) (2 trials)

metamizole (Novalgin) (1 trial)

Drugs in Phase 3 Trials (8)

Key: Hypera Pharma (0) Acquired (8)

betamethasone (celestone) (1 trial)

caffeine (1 trial)

chondroitin (1 trial)

dexchlorpheniramine maleate (polaramine) (5 trials)

glucosamine (1 trial)

guaifenesin (1 trial)

prednisone (meticorten) (1 trial)

pseudoephedrine (Benylin) (1 trial)

Indications

Overview

Highest Phase: None
# of Trials: 9
# of Trial APIs: 11